Dr. Edelman’s 90-year-old mom (the short one) wrote this article with her friend Soni, who was diagnosed with type 2 diabetes later in life. Getting type 2 and taking control of it gave Soni new energy, new clothes and a new flame!
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →
Evidence-based hope is letting people know that things are different than they were even 20 years ago. We now know that that with well-managed type 1 or type 2 diabetes, the odds are good you’re going to live a long and healthy life.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
read more →
